Express Yearling (Canada)

Manufacturer: Boehringer

Bovine Rhinotracheitis-virus Diarrhea Vaccine, Modified Live Virus

veterinary Use Only

indications

For vaccination of healthy, susceptible cattle as an aid in the prevention of respiratory disease caused by infectious bovine rhinotracheitis (IBR) virus and bovine virus diarrhea (BVD) virus types 1 and 2. This product contains BVD types 1 and 2.

Directions And Dosage

Rehydrate the vaccine by aseptically adding the accompanying liquid diluent to the vaccine vial. Shake well and use immediately. Using aseptic technique, inject 2 mL either intramuscularly or subcutaneously. Calves vaccinated before 6 months of age should be revaccinated at 6 months or at weaning. A 2 mL booster dose is recommended annually.

Note

It is possible that healthy appearing cattle can be persistently infected with or incubating virulent BVD virus at the time of vaccination. In view of these findings and suggested causes, BVD vaccine is contraindicated in persistently infected cattle and use should be limited only to healthy, immunocompetent, unstressed, nonpregnant cattle.

Precautions

Store in dark at 2-7°C. Avoid freezing. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Stressed cattle should not be vaccinated. Do not use in pregnant cows or calves nursing pregnant cows. Burn containers and all unused contents. Injection site swelling may occur. Anaphylactoid reactions may occur. Antidote: Epinephrine. Preservative: Neomycin.

Manufactured by: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.

U.s. Veterinary License No. 124

Manufactured For: Boehringer Ingelheim (canada) Ltd., Burlington, Ontario L7l 5h4

50 Doses, Rehydrate to 100 mL

This package contains one 50 dose vial of MLV vaccine and one 100 mL vial of liquid diluent.

10310-04

Nac No.

12300583